Adherence to MHRA Guidelines for Valproate Prescribing in General Adult Psychiatry
Aims: Valproate is widely prescribed for psychiatric conditions, particularly bipolar disorder, but carries significant teratogenic risks. The Medicines and Healthcare products Regulatory Agency (MHRA) mandates strict prescribing guidelines, particularly for women of childbearing potential, to mitig...
| 出版年: | BJPsych Open |
|---|---|
| 第一著者: | |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Cambridge University Press
2025-06-01
|
| オンライン･アクセス: | https://www.cambridge.org/core/product/identifier/S2056472425105863/type/journal_article |
| 要約: | Aims: Valproate is widely prescribed for psychiatric conditions, particularly bipolar disorder, but carries significant teratogenic risks. The Medicines and Healthcare products Regulatory Agency (MHRA) mandates strict prescribing guidelines, particularly for women of childbearing potential, to mitigate these risks. Additionally, emerging evidence suggests potential risks for men, including infertility and neurodevelopmental concerns. |
|---|---|
| ISSN: | 2056-4724 |